Pharming PHAR
NASDAQ PHAR
$10.12 +0.11 (+1.09%)
As of: Sep 30, 2026 · 10:24 AM EDT

Pharming (PHAR) Current Deferred Tax Assets (2019 - 2022)

Updated

Pharming (PHAR) reported Current Deferred Tax Assets of $13.56 million for Q4 2022, down 46.6% from $25.36 million a year earlier.

Analysis

Pharming (PHAR) Current Deferred Tax Assets (2019 - 2022) Analysis & Trends

Dating back to Q4 2019, Pharming's Current Deferred Tax Assets record includes 4 quarters.

  • Current Deferred Tax Assets has declined for three consecutive years, with a three-year compound annual growth rate of -26.9% (FY2019 to FY2022).
  • By year, Current Deferred Tax Assets came in at $25.36 million in FY2021 (-19.1%), $31.37 million in FY2020 (-9.5%) and $34.64 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Pharming 738.17 Mn -91.99 Mn 141.47 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 13.56 Mn
Dec 31, 2021 25.36 Mn
Dec 31, 2020 32.75 Mn
Dec 31, 2019 34.24 Mn
API Access

Pharming Current Deferred Tax Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-tax-assets&ticker=PHAR&period=max&api_key=YOUR_API_KEY